Naproxen
Product Images NDC 61919-162

2 FDA label images from Direct Rx · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Naproxen (NDC 61919-162). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Direct Rx, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

162 (162 60)

162 (162 60)
NAPROXEN 375 mg tablet bottle label showing a generic for Naprosyn, with 60 tablets per bottle. The label includes dosing warnings, directions to avoid exposure to children, and manufacturer information for Glenmark Pharmaceuticals Inc. It is labeled by DIRECT RX with NDC 61919-162.*
FDA Label Image

61919-162-30 (61919 162 30)

61919-162-30 (61919 162 30)
Packaging label for NAPROXEN 375 mg tablets, with a package count of 30 tablets. The label identifies the product as generic for NAPROSYN and lists Naproxen USP 375 mg as the active ingredient per tablet. The product is labeled by DIRECT RX with the NDC number 61919-162. Additional lot, sample, and expiration details are present, along with a barcode and QR code.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.